Modified maximal thymectomy is safe and efficient in the treatment of thymomas. WHO histology is the prime determinant of tumor aggressiveness and patient survival. Paraneoplastic myasthenia gravis and its outcome after thymectomy is significantly correlated with the WHO classification subtypes; however, lower CSR rates are not necessarily associated with more aggressive histological subgroups.
Gallbladder polyps are relatively common in adults and affect approximately 5% of the population. Polypoid lesions of the gallbladder are asymptomatic and are detected during abdominal ultrasonography performed for unrelated conditions. Although the majority of gallbladder polyps are benign, malignant transformation is a concern. The differentiation of benign from malignant lesions can be challenging. Several features, including polyp size, number, rapid growth, sessile lesion, patient age and gallbladder wall thickening are important discriminating features between benign and malignant polyps and may increase the risk of gallbladder cancer. Histopathologic analysis of polypoid lesions of the gallbladder continues to be the gold standard to identify malignancy. Ultrasound has been used extensively in the pre-operative management of these lesions, but modern ultrasound techniques are unable to differentiate between benign and malignant polyp of the gallbladder with any certainty. We recommend surgical treatment of polypoid lesions of the gallbladder in symptomatic patients, as well as in asymptomatic individuals over 50 years of age, or those whose polyps are solitary, sessile, greater than 6 mm in diameter, that demonstrate rapid growth, vascularity and invasion or are associated with gallstones.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.